Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05458752
Status:
COMPLETED
Last Update Posted:
2023-07-05
First Post:
2022-06-28
Brief Title:
Pneumocystis Jirovecii Pneumonia in Non-HIV-infected Immunocompromised Patients
Sponsor:
Central Hospital Nancy France
Organization:
Central Hospital Nancy France
Study Overview
Official Title:
Pneumocystis Jirovecii Pneumonia in Non-HIV-infected Immunocompromised Patients a Prognostic Observational Retrospective Monocentre Study
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PnP-HIV-Free
Brief Summary:
Pneumocystis jirovecii pneumonia PjP is a rare infectiouse disease with a high level of mortality PjP is a classical opportunistic infection which concern HIV infected and immunocompromised patients During the past decade several therapeutics progresses have been done in oncology immunology and hematology As a consequence patients benefited of greater treatment efficacy but are exposed to a higher risk of opportunistic infections as PjP The investigators hypothesis is that PjP incidence increase and its form is depending of underlying immune conditions The investigators aim to describe its incidence the PjP forms depending on comorbidities and to identifiy pronostics factors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None